Performance analysis of innovation development of state-owned pharmaceutical enterprises in ChinaSHI Sheng-yi, KE Chao-jing, WU Xiao-ming1081-1086
Analysis of the current situation of patent application of pharmaceutical manufacturing enterprises in Liaoning province and the corresponding suggestionsZHAO Zhe, SHENG Meng-di, FAN Jun-yan, LIU Ya-wen, DONG Li1087-1092
Pharmacology and clinical studies on erdafitinib: the first targeting therapeutic agent for the treatment of advanced or metastatic bladder cancerLI Xiao, ZHANG Yan-hua1093-1096
Fundamental principles for assessment of the quality and efficacy of generic ophthalmic drugsTIAN Na, ZHANG Xing-yi1097-1102
The hydrolysis of Aβ42 by truncated metalloproteinase sADAM 10WANG Zi-rou, SUN Xin, FU Xin-yue, LI Qi-qi, ZHANG Fang, CHEN Hao, LI Qian, ZHAO Bao-quan, SUN Man-ji1103-1109
Characteristics, clinical use and market analysis of currently available erythropoietins for the therapy of anemiaGAO Feng, REN Li-wen, LI Xiao-wen, YANG Chun, WANG Jin-hua, DU Guan-hua1110-1117
Evaluation of the effects of different solvents on the susceptibility of Candida species to fluconazoleHUANG Jing-jing, CHEN Xin-fei, XIAO Meng, ZHANG Ge, XU Ying-chun1118-1121
Advances in zinc binding groups of histone deacetylase inhibitorsZHU Yu-yao, WANG Yu, MA Jun-jie1122-1130
Nintedanib in idiopathic pulmonary fibrosis: an overviewCHEN Hai-hong, YANG Jun, CHEN Zhao-hui, WANG Dong, CHI Xian-su, ZHU Qing-jun1131-1135
Research progress in adjusting tumor microenvironment by traditional Chinese medicine combined with chemotherapyLI Mu-lan, ZHANG Wu-gang, YANG Wu-liang, LI Guo-feng, DU Wen-di, ZHANG Chen, CHEN Hai-fang1136-1142